Remove IPO Remove Negotiation Remove Workshop
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40
article thumbnail

Elevating Expertise: Senior Advisor Spotlight, Bob Bicksler

Focus Investment Banking

The JML transaction is the latest in a long line of successful deals Bob has negotiated for clients throughout the years. in $8B transaction), howstuffworks.com International (merged into NASDAQ company), Global Metro Networks, MetroNet (IPO), Performance Awareness Corp. IPO), and Megapath Communications.

M&A 52